{
     "PMID": "14642852",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20040212",
     "LR": "20141120",
     "IS": "0006-8993 (Print) 0006-8993 (Linking)",
     "VI": "993",
     "IP": "1-2",
     "DP": "2003 Dec 12",
     "TI": "5-HT7 receptors increase the excitability of rat hippocampal CA1 pyramidal neurons.",
     "PG": "230-4",
     "AB": "In the CA1 area of rat hippocampal slices, a combined application of 5-CT, a potent 5-HT(1A) and 5-HT(7) receptor agonist, and WAY 100635, a selective 5-HT(1A) receptor antagonist, resulted in a reversible increase of the CA1 extracellular population spike amplitude. In whole-cell recording from identified pyramidal neurons, the effects of 5-CT applied in the presence of WAY 100635 involved a reduction of the slow afterhyperpolarization (sAHP) and the frequency adaptation of action potential firing, which could be blocked by a specific 5-HT(7) receptor antagonist SB 269970. The results indicate that the activation of 5-HT(7) receptors increases the excitability of hippocampal CA1 pyramidal cells.",
     "FAU": [
          "Tokarski, Krzysztof",
          "Zahorodna, Agnieszka",
          "Bobula, Bartosz",
          "Hess, Grzegorz"
     ],
     "AU": [
          "Tokarski K",
          "Zahorodna A",
          "Bobula B",
          "Hess G"
     ],
     "AD": "Department of Physiology, Institute of Pharmacology, Polish Academy of Sciences, Smetna 12, 31-343, Krakow, Poland.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Phenols)",
          "0 (Piperazines)",
          "0 (Pyridines)",
          "0 (Receptors, Serotonin)",
          "0 (SB 269970)",
          "0 (Serotonin Antagonists)",
          "0 (Sulfonamides)",
          "0 (serotonin 7 receptor)",
          "333DO1RDJY (Serotonin)",
          "71IH826FEG",
          "(N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxa",
          "mide)"
     ],
     "SB": "IM",
     "MH": [
          "Action Potentials/drug effects",
          "Animals",
          "Dose-Response Relationship, Drug",
          "Dose-Response Relationship, Radiation",
          "Drug Interactions",
          "Electric Stimulation",
          "Excitatory Postsynaptic Potentials/drug effects/physiology",
          "Hippocampus/*cytology/drug effects",
          "In Vitro Techniques",
          "Male",
          "Phenols/pharmacology",
          "Piperazines/pharmacology",
          "Pyramidal Cells/drug effects/*physiology",
          "Pyridines/pharmacology",
          "Rats",
          "Rats, Wistar",
          "Receptors, Serotonin/drug effects/*physiology",
          "Serotonin/*metabolism",
          "Serotonin Antagonists/pharmacology",
          "Sulfonamides/pharmacology"
     ],
     "EDAT": "2003/12/04 05:00",
     "MHDA": "2004/02/13 05:00",
     "CRDT": [
          "2003/12/04 05:00"
     ],
     "PHST": [
          "2003/12/04 05:00 [pubmed]",
          "2004/02/13 05:00 [medline]",
          "2003/12/04 05:00 [entrez]"
     ],
     "AID": [
          "S0006899303037338 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2003 Dec 12;993(1-2):230-4.",
     "term": "hippocampus"
}